Renal cell carcinoma echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Ultrasound== | ==Ultrasound== | ||
Ultrasound may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound. | Ultrasound (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound. | ||
{|border="1" style="border-collapse:collapse; text-align:left;" cellpadding="5" align="center" | |||
|+ '''''Use of US in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }} </ref>''''' | |||
| bgcolor="#d9ff54"|'''Patient Profile''' || bgcolor="#d9ff54"|'''Use of US'''|| bgcolor="#d9ff54"|'''Evidence Strength''' | |||
|- | |||
| bgcolor="#ececec"|'''Low Risk Patient (pT1, N0, Nx)''' ||US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative||C | |||
|- | |||
| bgcolor="#ececec"|'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician|| C | |||
|} | |||
==References== | ==References== | ||
Revision as of 19:36, 11 January 2014
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma echocardiography or ultrasound |
|
Renal cell carcinoma echocardiography or ultrasound in the news |
|
Blogs on Renal cell carcinoma echocardiography or ultrasound |
|
Risk calculators and risk factors for Renal cell carcinoma echocardiography or ultrasound |
Overview
Ultrasound
Ultrasound (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound.
| Patient Profile | Use of US | Evidence Strength |
| Low Risk Patient (pT1, N0, Nx) | US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative | C |
| Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) | Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician | C |
References
- ↑ Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.